BACKGROUND: Survivors of childhood cancer are at significant risk for serious chronic health conditions and subsequent cancers because of their prior treatment exposures. However, little is known about survivors' perceptions of their future health risks. METH-ODS: This study examined self-reported levels of concern about future health and subsequent cancer in 15,620 adult survivors of childhood cancer (median age, 26 years; median time since diagnosis, 17 years) and 3991 siblings in the Childhood Cancer Survivor Study. The prevalence of concerns was compared between survivors and siblings, and the impact of participant characteristics and treatment exposures on concerns was examined with multivariable modified Poisson regression to estimate relative risks (RRs) and 95% confidence intervals (CIs). RESULTS: A substantial proportion of survivors were not concerned about their future health (31%) or developing cancer (40%). The prevalence of concern in survivors was modestly higher (RR for future health, 1.12; 95% CI, 1.09-1.15) or similar (RR for subsequent cancer, 1.02; 95% CI, 0.99-1.05) in comparison with siblings. Survivors exposed to high doses of radiation (20 Gy) were more likely to report concern (RR for future health, 1.13; 95% CI, 1.09-1.16; RR for subsequent cancer, 1.14; 95% CI, 1.10-1.18), but 35% of these high-risk survivors were not concerned about developing cancer, and 24% were not concerned about their future health. CONCLUSIONS: A substantial subgroup of survivors were unconcerned about their future health and subsequent cancer risks, even after exposure to treatments associated with increased risk. These survivors may be less likely to engage in beneficial screening and risk-reduction activities. Cancer V C 2018 American Cancer Society.
INTRODUCTION
Survival after a childhood cancer diagnosis has improved dramatically in recent decades, with more than 84% of children now surviving at least 5 years. 1 Most become long-term survivors, and this has resulted in a growing population that exceeds 420,000 in the United States. 2 Improvements in survival have prompted increased recognition of the importance of adverse late health outcomes experienced by survivors as a result of childhood cancer treatments. Potential late effects include organ dysfunction, infertility, subsequent neoplasms, cognitive dysfunction, psychological distress, and mortality. 2, 3 Elevated awareness of late effects in the medical community prompted the development of clinical guidelines for the care and screening of childhood cancer survivors based on treatment histories, 4 but relatively little is known regarding survivors' perceptions of their future health risks.
Prior studies have examined psychological health in childhood cancer survivors with standardized measures of anxiety, depression, and posttraumatic stress, [5] [6] [7] but the specific health concerns endorsed by survivors have not been well studied. Prior studies were small and were focused on cancer-related and general health worries as barriers to postcancer adjustment and psychological well-being. [8] [9] [10] [11] [12] [13] [14] [15] [16] However, concern about future health is justified for many survivors, particularly those treated with high-dose radiation and chemotherapy. Survivors have a 5-fold increased risk of severe, disabling, life-threatening, or fatal health conditions in comparison with siblings, and the estimated prevalences by the age of 45 years for any chronic health condition and for a serious/disabling or life-threatening condition are 95.5% and 80.5%, respectively. 17, 18 Up to 1 in 5 survivors will develop a subsequent neoplasm within 30 years after their treatment, and the risk of malignant neoplasms is 6-fold higher in survivors versus the general population. 19, 20 Some survivors may experience excessive worry, but a lack of appropriate concern about increased health risks is also troubling, potentially limiting engagement in beneficial screening and health behaviors.
The goal of this study was to examine the level of concern reported by adult survivors of childhood cancer when they were asked specifically about their future health or the development of subsequent cancers. We used the Childhood Cancer Survivor Study (CCSS) to compare selfreported levels of concern between 15,620 survivors and 3991 siblings and to examine whether the concern endorsed by survivors was reflective of their potential risks for late effects associated with specific treatment exposures. In addition, we assessed longitudinal changes in levels of concern.
MATERIALS AND METHODS

Population
The CCSS is a retrospective cohort study of children who were diagnosed (age < 21 years) with cancer (leukemia, central nervous system tumor, Hodgkin lymphoma, nonHodgkin lymphoma, kidney cancer, neuroblastoma, softtissue sarcoma, or bone sarcoma) at 1 of 27 participating institutions in North America between January 1, 1970, and December 31, 1999 , and survived at least 5 years. Full details of the study methodology have been published previously. [21] [22] [23] A randomly selected group of their siblings was recruited as a comparison group. Baseline questionnaires were completed for 23,810 survivors. Survivors diagnosed from 1970 to 1986 were recruited initially (the original cohort), with baseline questionnaires first administered in 1994. The cohort was subsequently expanded to include survivors diagnosed from 1987 to 1999 (the more recent cohort), with baseline questionnaires first administered in 2008. Participants and nonparticipants were similar with respect to demographic and cancer-related characteristics. 22 Follow-up questionnaires were administered every 2 to 3 years. Participants provided informed consent, and the study was approved by all relevant institutional review boards.
Questionnaires were completed by parents for children younger than 18 years, so we restricted our analysis to adult participants. We excluded survivors who were younger than 18 years at the baseline (n 5 5109), those who did not provide self-reported concern data (n 5 2485), and those with a diagnosis not included in the expanded cohort (n 5 596); this resulted in an analytic cohort of 15,620 survivors (Supporting Fig. 1 ). Similar exclusions resulted in 3991 adult siblings. A follow-up questionnaire with the same concern questions administered in 2014-2016 was completed by 7601 survivors (49% of the baseline).
Data Collection and Measures
Study participants completed a baseline questionnaire that included questions on demographics, lifestyle behaviors, psychosocial variables, and a wide array of health outcomes. Chronic health conditions were classified and graded on the basis of the Common Terminology Criteria for Adverse Events (version 4.0). 24 Subsequent cancers were identified via self-report and were verified by an expert review of pathology reports and medical records or via linkage with the National Death Index. Detailed data on treatments received within the first 5 years after the childhood cancer diagnosis were abstracted from medical records, and body region-specific dosimetry was performed. 25 Participants rated how concerned they were about 1) their future health and 2) developing a cancer. Responses were based on a 5-point Likert scale: very concerned, somewhat concerned, concerned, not very concerned, or not at all concerned. The primary outcome was determined a priori as a binary variable, with responses of "not at all concerned" and "not very concerned" combined as a "lack of concern" and with the other 3 responses categorized as "concern." The questionnaire also included the Brief Symptom Inventory 18, and the Anxiety subscale categorized participants with clinical anxiety (T score 63).
26,27
Statistical Analysis
We examined the prevalence of different levels of concern about future health or developing cancer at the baseline and reported proportions for survivors and siblings. Multivariable regression modeling was used to compare the prevalence of concern between survivors and siblings; it was adjusted for sex, race/ethnicity, age (as a continuous variable), education, and decade of diagnosis. We included analyses stratified by whether survivors had already experienced a severe, disabling, or life-threatening (Common Terminology Criteria for Adverse Events grade 3 or 4) chronic health condition (concern about future health) or a subsequent neoplasm (concern about developing cancer). Modified Poisson regression with robust error variances was used to estimate relative risks (RRs) and 95% confidence intervals (CIs) in the context of common outcomes. 28, 29 To examine whether differences in concern between survivors and siblings were commensurate with differences in the actual risk of adverse outcomes, we contrasted RRs for concerns with previously published RRs for developing grade 3 to 5 chronic conditions or subsequent neoplasms comparing survivors and siblings. 18 Among survivors, multivariable modified Poisson regression models with robust error variances were used to estimate associations between participant and treatment characteristics and prevalence of concern.
Finally, we compared the prevalence of concerns at the baseline and follow-up among survivors who provided these data. Because the time interval between the baseline and the follow-up was substantially shorter for survivors in the more recent cohort (median interval, 4.6 years; range, 1.2-8.5 years) versus the original cohort (median interval, 19.4 years; range, 11.0-23.9 years), longitudinal comparisons were examined separately for these groups.
RESULTS
Concern levels at the baseline were examined in 15,620 survivors with a median age of 26 years (interquartile range, 22-31 years) and a median time since their childhood cancer diagnosis of 17 years (interquartile range, 14-21 years; Table 1 ). Survivors were predominantly non-Hispanic white (85%) and had at least a high school education (92%), with 34% having graduated from college. Siblings were generally similar to survivors but were more likely to be female (54% vs 48%), non-Hispanic white (91%), and college-educated (43%). Survivors were more likely to have experienced at least 1 severe, disabling, or life-threatening chronic health condition before the baseline (26% vs 9%).
A lack of concern about future health was reported by 30.7% of the survivors (95% CI, 30.0%-31.4%) and 33.6% of siblings (95% CI, 32.1%-35.1%; Table 2 and Supporting Fig. 2 ). The prevalence of a lack of concern was higher among survivors who had not experienced a grade 3 or 4 chronic condition (33.1%) in comparison with those who had experienced such a condition (24.4%). With adjustments for age, sex, race/ethnicity, education, and decade of diagnosis, survivors were more likely than siblings to report concern about future health (RR, 1.12; 95% CI, 1.09-1.15; Table 3 ).
More than a third of the survivors (39.9%; 95% CI, 39.1%-40.7%) reported a lack of concern about developing subsequent cancer; this proportion was similar among siblings (38.4%; 95% CI, 36.9%-39.9%). However, the prevalence of a lack of concern about cancer was lower among survivors who had already been diagnosed with a subsequent neoplasm (24.4%). This subgroup was more likely than siblings to report concern about developing additional cancers (RR, 1.21; 95% CI, 1.14-1.28), but concern among survivors who had not already developed a subsequent neoplasm was similar to that among siblings (RR, 1.02; 95% CI, 0.98-1.05).
Survivors were more likely to report concern about future health or developing cancer if they were female, were non-Hispanic black or Hispanic, were older, were identified as having clinical anxiety, or had already experienced a grade 3 or 4 chronic condition or subsequent cancer (Supporting Table 1 ). They were less likely to report either concern with increased education and elapsed time since their childhood cancer diagnosis. With adjustments made for the follow-up time, survivors diagnosed in more recent decades were less likely to report concern about future health. Not all percentages add up to 100 due to rounding.
Survivors exposed to radiation were modestly more likely to report concern about future health than those without radiotherapy (RR for < 20 Gy, 1.07; 95% CI, 1.02-1.11), and the association was stronger for survivors exposed to 20 Gy (RR, 1.13; 95% CI, 1.09-1.16; Table  4 ). Exposure was associated with increased concern about future health for chest (RR, 1.08; 95% CI, 1.05-1.10) and neck radiation (RR, 1.08; 95% CI, 1.05-1.11) but not for cranial radiation. After adjustments for radiation exposure, survivors were more likely to report concern about future health if they were exposed to alkylating agents (RR, 1.07; 95% CI, 1.04-1.10) or anthracycline chemotherapy (RR, 1.06; 95% CI, 1.03-1.09). Associations between these treatment variables and concern about developing cancer were similar to those for concern about future health (Table 4) .
Survivors who completed the follow-up questionnaire were more likely to be female, be non-Hispanic white, and have more education in comparison with those who did not (Supporting Table 2 ). Among these survivors in the original cohort (median time interval, 19 years), the prevalence of a lack of concern about future health increased from 25.3% (95% CI, 23.9%-26.7%) at the baseline to 28.8% (95% CI, 27.4%-30.3%) at the followup; the prevalence of a lack of concern about developing cancer increased from 36.9% (95% CI, 35.8%-38.4%) to 40.9% (95% CI, 39.3%-42.5%; Table 2 and Fig. 1A ). In the more recent cohort (median time interval, 4.6 years), the prevalence of a lack of concern about future health decreased from 38.1% (95% CI, 36.6%-39.7%) to 35.4% (95% CI, 33.9%-36.9%); the prevalence of a lack of concern about developing cancer decreased from 42.6% (95% CI, 41.0%-44.2%) to 40.1% (95% CI, 38.5%-41.7%; Fig. 1B ). Among more recent cohort participants exposed to cardiotoxic therapies, those who reported concern about their future health at the baseline reported a higher prevalence of echocardiogram screening on the follow-up questionnaire (56.2% vs 51.0% among those without concern; P 5 .03). Among participants exposed to radiation, those with concern about developing cancer at the baseline reported a higher prevalence of surveillance for skin cancer (70.9% vs 62.5% among those without concern; P < .0001) or breast cancer (66.3% vs 51.0% among those without concern; P 5 .002) on the follow-up questionnaire (Supporting Table 3 ).
DISCUSSION
In the largest study to date that specifically examined adult childhood cancer survivors' concerns about their future health and risk of developing cancer, substantial proportions of survivors (31% and 40%, respectively) reported a lack of concern. Although concern varied modestly by Abbreviations: CI, confidence interval; RR, relative risk. a Adjusted for age, sex, race/ethnicity, year of diagnosis, education, and prior grade 3 or 4 chronic conditions (concern about future health) or subsequent neoplasms (concern about developing cancer).
treatment exposures, the proportion of survivors reporting a lack of concern after exposure to therapies associated with an increased risk of late effects was surprisingly high. These results suggest that a sizable subgroup of survivors may not fully understand or acknowledge their increased risk of late effects and, therefore, may be less likely to engage in beneficial screening and risk-reduction activities.
The CCSS provides a unique opportunity for comparing levels of concern between survivors and siblings in the context of established differences in the risk of late effects within the same study population. Survivors were less likely to report a lack of concern in comparison with siblings, but the difference in concerns was quite small in comparison with the disparity in actual risk for chronic health conditions or subsequent cancer. A prior CCSS analysis found that survivors had a 4.9-fold increased risk of grade 3 to 5 chronic conditions in comparison with siblings, 18 whereas we found that survivors had a 1.2-fold increased risk of reporting concern about future health. Similarly, although a previous analysis found an 8.5-fold increased risk of subsequent cancer for survivors versus siblings, 18 we found that concern about developing cancer was similar in these 2 groups. Siblings of childhood cancer survivors may not be representative of the general population because of their family experience, but even so, it is notable that more than a third of survivors were not concerned about their future risk of cancer. Survivors at highest risk for subsequent cancers due to their treatment exposures were more likely to report concern than those at lower risk, but the proportion of survivors exposed to therapies increasing their risk of late health effects who were nonetheless unconcerned about these risks was substantial. This was particularly striking for concerns about developing cancer: more than a third of survivors exposed to 20 Gy of radiation reported a lack of concern about their cancer risk. The Children's Oncology Group (COG) long-term follow-up guidelines (http://survivorshipguidelines.org/) call for enhanced screening for survivors exposed to high-risk treatments, but a lack of concern may prevent survivors from acknowledging or following such guidelines. A lack of concern in our study was associated with a reduced prevalence of surveillance for heart disease, skin cancer, or breast cancer and, in previous studies, has been associated with decreased odds of completing breast examinations, mammograms, Papanicolaou tests, testicular self-examinations, colonoscopy, or general or cancer-related medical care. [30] [31] [32] Fewer than half of highrisk survivors in the CCSS were adherent to recommended cancer screening guidelines, so characterizing groups at risk for nonadherence and potential targets for intervention is important. 33 A lack of concern despite elevated risk in some survivors may stem in part from a lack of knowledge about either their prior cancer treatments or the associated risks of late effects. In a substudy of 653 CCSS survivors, 91% could accurately report their childhood cancer diagnosis in at least a general sense, but only 70% could recall the location of their radiotherapy, and less than half could recall receiving anthracycline chemotherapy. 34 Notably, a lack of concern about future health was associated with less awareness about radiation history. In addition, only 35% of the participants believed that past therapies could cause a serious health problem with the passage of time. Other studies have found similar deficits in knowledge of treatment and the risk of late effects. [35] [36] [37] [38] [39] We examined levels of concern among childhood cancer survivors, which may be distinct from previous studies focused on high levels of worry as a threat to psychosocial well-being. 8, [10] [11] [12] [13] [14] [15] [16] Limited evidence suggests that survivors worry less about general health issues than those without a cancer history but have a higher degree of worry about cancer-specific issues such as recurrence or a new cancer. 10, 14 Among survivors, female sex has been consistently associated with higher levels of worry, whereas older age and lower education have been linked to worries in only some studies. 10, 12, [14] [15] [16] One previous study found that survivors treated with the most intensive therapies had more cancer worry than those treated with the least intensive therapies, 12 whereas another found no significant association between treatment and worries. 10 The prevalence of concerns about future health and developing cancer was largely stable over time among survivors with longitudinal data. The administration of the CCSS baseline questionnaire started in 1994, well before the release of the first COG survivorship care guidelines in 2004. 4 Despite these guidelines, more participants reported a lack of concern over time, whereas fewer were very concerned. The salience of concerns about cancer and its treatment likely fades with increasing time since diagnosis, but as participants age, their risk of late effects remains elevated. 18 Survivors in the more recent cohort completed the baseline questionnaire after widespread dissemination of the COG guidelines, but the prevalence of a lack of concern remained high at the baseline and follow-up. Furthermore, a lack of concern persisted in CCSS participants despite numerous communications designed to educate survivors about risks associated with childhood cancer and treatments. The questionnaire did not capture the underlying motivation for reported levels of concern, so some survivors may in fact be aware of their health risks but maintain a sense of not being concerned. The goal of survivor education is not to unduly alarm survivors or induce worry, but the fact that the prevalence of some degree of concern was static or diminished over time suggests that more effective communication strategies are needed to ensure that survivors with an elevated risk of late effects are aware of these risks as they get older.
In addition to longitudinal data, the strengths of this study include the large sample size, the use of a sibling comparison group, and the ability to investigate the impact of both treatment factors and chronic health conditions. The questions about concern were not from a validated instrument, so comparisons with other research require caution. Longitudinal data were available for only 49% of the baseline cohort and, therefore, may not be fully representative of all survivors.
Survivors of childhood cancer face an increased risk of serious morbidity and mortality because of their prior exposure to radiation and chemotherapy, but some of these risks can potentially be mitigated through early detection and intervention as well as the adoption of healthy behaviors. [40] [41] [42] Our results indicate that a substantial subgroup of survivors are unconcerned about their future health and subsequent cancer risks, even after exposure to high-risk treatments. The majority of survivors do not participate in risk-based, survivor-focused medical care, so it is important that they be aware of their unique health risks and advocate for guideline-based care. 43 A lack of concern about potential late effects may be a barrier to such self-advocacy and may result in less adoption of healthy behaviors. A low level of concern may be appropriate in some survivors, but further efforts are needed to ensure that those in high-risk groups both understand and acknowledge their risk.
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